12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights significant pre-market movements in health care stocks on Wednesday. Notable gainers include Biodexa Pharmaceuticals, Carmell, Tempest Therapeutics, NovoCure, NeuroBo Pharmaceuticals, and Windtree Therapeutics. On the losing side, Novavax, Assembly Biosciences, Dogwood Therapeutics, INVO Bioscience, NewGenIvf Group, and ABVC BioPharma experienced declines.
October 16, 2024 | 12:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biodexa Pharmaceuticals saw a significant pre-market increase of 183.2%, reaching $14.19.
The substantial pre-market rise suggests strong investor interest or positive news, likely leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Carmell's stock rose by 38.87% to $0.48 in pre-market trading.
The significant pre-market gain indicates potential positive developments or investor sentiment, likely boosting short-term stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
NeuroBo Pharmaceuticals shares increased by 17.39% to $2.97 in pre-market.
The pre-market rise indicates positive investor sentiment or news, likely leading to a short-term price increase.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
NovoCure's stock increased by 22.27% to $21.74 in pre-market trading.
The significant pre-market gain suggests strong investor interest or positive news, likely boosting short-term stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Tempest Therapeutics shares increased by 24.82% to $1.46 in pre-market.
The pre-market rise suggests positive investor sentiment or news, likely leading to a short-term price increase.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Windtree Therapeutics shares rose 16.33% to $0.77 in pre-market trading.
The pre-market gain suggests positive investor sentiment or news, likely boosting short-term stock price.
CONFIDENCE 80
IMPORTANCE 55
RELEVANCE 100
NEGATIVE IMPACT
ABVC BioPharma shares declined by 8.86% to $0.54 in pre-market.
The pre-market decline indicates negative investor sentiment or news, likely leading to a short-term price decrease.
CONFIDENCE 75
IMPORTANCE 55
RELEVANCE 100
NEGATIVE IMPACT
Assembly Biosciences shares decreased by 18.69% to $15.06 in pre-market.
The pre-market decline indicates negative investor sentiment or news, likely leading to a short-term price decrease.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Dogwood Therapeutics shares declined by 13.67% to $3.16 in pre-market.
The pre-market decline suggests negative investor sentiment or news, likely leading to a short-term price decrease.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
INVO Bioscience shares fell 11.76% to $0.9 in pre-market trading.
The pre-market decline indicates negative investor sentiment or news, likely leading to a short-term price decrease.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
NewGenIvf Group shares fell 10.21% to $1.76 in pre-market trading.
The pre-market decline suggests negative investor sentiment or news, likely leading to a short-term price decrease.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Novavax stock declined by 19.5% to $10.14 in pre-market trading.
The significant pre-market decline suggests negative investor sentiment or news, likely leading to a short-term price decrease.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100